Korro Bio Inc — Cash Flow (NASDAQ:KRRO) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Cash from operating activities 45.19 M76.06 M58.24 M67.28 M60.07 M 68.35 M Cash from investing activities 10.4 M66.13 M31.13 M11.16 M123.35 M 31.84 M Cash from financing activities 56.69 M1.36 M577 K187.76 M69.36 M 1.24 M Free cash flow 38.52 M73.14 M58.24 M59.45 M42.17 M 66.47 M

Nachrichten

Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates

Clear Street upgrades Korro Bio stock rating on hyperammonemia program potential

Strength Seen in Korro Bio, Inc. (KRRO): Can Its 13.9% Jump Turn into More Strength?

Korro Bio stock rating upgraded by H.C. Wainwright to Buy on new drug potential

Piper Sandler upgrades Korro Bio stock rating to Overweight on UCD treatment

Chardan Capital upgrades Korro Bio stock to Buy on KRRO-121 potential

Korro Bio, Inc. (KRRO) Analyst/Investor Day - Slideshow (NASDAQ:KRRO) 2026-01-28

William Blair reiterates Market Perform rating on Korro Bio stock

Raymond James reiterates Market Perform rating on Korro Bio stock

Cantor Fitzgerald upgrades Korro Bio stock to Overweight on UCD program

Korro Bio stock holds steady as Jones Trading reiterates Hold rating

Clear Street raises Korro Bio stock price target to $10 on new lead program